Cartagenia
ExitedProviding diagnostic systems and services enabling genetic labs and clinicians to perform correct genetic analyses.
Cartagenia has raised €6.5M across 2 funding rounds from 1 investor, most recently a round in May 2014. Based in Leuven, Belgium; founded 2008; active in Healthtech. The company has exited (2014). Data as of 28 Oct 2026.
Total raised
€6.5M
€6,450,000
Funding rounds
2
Investors
1
distinct backers
Active since
2011-10
latest 2014-05
Funding by year
EUR raised per yearCartagenia — funding by year — interactive chart.
Data table
| Cartagenia — funding by year | |
|---|---|
| 2011 | €2.2M |
| 2014 | €4.3M |
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-05-01 | Other | €4.3M | Capricorn Partners | View deal → |
| 2011-10-01 | Early VC | €2.2M | — | View deal → |
Exit
Type
acquisition
Date
Oct 2014
Value
—
Acquiror
—
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData